Cargando…

Corrigendum: An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection

Detalles Bibliográficos
Autores principales: Ye, Chuantao, Wang, Dan, Liu, He, Ma, Hongwei, Dong, Yangchao, Yao, Min, Wang, Yuan, Zhang, Hui, Zhang, Liang, Cheng, Linfeng, Xu, Zhikai, Lei, Yingfeng, Zhang, Fanglin, Ye, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057847/
https://www.ncbi.nlm.nih.gov/pubmed/32180732
http://dx.doi.org/10.3389/fphar.2020.00201
_version_ 1783503747379363840
author Ye, Chuantao
Wang, Dan
Liu, He
Ma, Hongwei
Dong, Yangchao
Yao, Min
Wang, Yuan
Zhang, Hui
Zhang, Liang
Cheng, Linfeng
Xu, Zhikai
Lei, Yingfeng
Zhang, Fanglin
Ye, Wei
author_facet Ye, Chuantao
Wang, Dan
Liu, He
Ma, Hongwei
Dong, Yangchao
Yao, Min
Wang, Yuan
Zhang, Hui
Zhang, Liang
Cheng, Linfeng
Xu, Zhikai
Lei, Yingfeng
Zhang, Fanglin
Ye, Wei
author_sort Ye, Chuantao
collection PubMed
description
format Online
Article
Text
id pubmed-7057847
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-70578472020-03-16 Corrigendum: An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection Ye, Chuantao Wang, Dan Liu, He Ma, Hongwei Dong, Yangchao Yao, Min Wang, Yuan Zhang, Hui Zhang, Liang Cheng, Linfeng Xu, Zhikai Lei, Yingfeng Zhang, Fanglin Ye, Wei Front Pharmacol Pharmacology Frontiers Media S.A. 2020-02-27 /pmc/articles/PMC7057847/ /pubmed/32180732 http://dx.doi.org/10.3389/fphar.2020.00201 Text en Copyright © 2020 Ye, Wang, Liu, Ma, Dong, Yao, Wang, Zhang, Zhang, Cheng, Xu, Lei, Zhang and Ye. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Ye, Chuantao
Wang, Dan
Liu, He
Ma, Hongwei
Dong, Yangchao
Yao, Min
Wang, Yuan
Zhang, Hui
Zhang, Liang
Cheng, Linfeng
Xu, Zhikai
Lei, Yingfeng
Zhang, Fanglin
Ye, Wei
Corrigendum: An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection
title Corrigendum: An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection
title_full Corrigendum: An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection
title_fullStr Corrigendum: An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection
title_full_unstemmed Corrigendum: An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection
title_short Corrigendum: An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection
title_sort corrigendum: an improved enzyme-linked focus formation assay revealed baloxavir acid as a potential antiviral therapeutic against hantavirus infection
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057847/
https://www.ncbi.nlm.nih.gov/pubmed/32180732
http://dx.doi.org/10.3389/fphar.2020.00201
work_keys_str_mv AT yechuantao corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection
AT wangdan corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection
AT liuhe corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection
AT mahongwei corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection
AT dongyangchao corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection
AT yaomin corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection
AT wangyuan corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection
AT zhanghui corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection
AT zhangliang corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection
AT chenglinfeng corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection
AT xuzhikai corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection
AT leiyingfeng corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection
AT zhangfanglin corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection
AT yewei corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection